Flovent Diskus (fluticasone propionate inhalation powder)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

July 2016

ADVERSE REACTIONS

Postmarketing Experience

Infections and Infestations: Esophageal candidiasis.